Buduća događanja

On 21 March 2023, DROI will hold a public hearing on "The state of human rights in Algeria in the framework of the renewed partnership with the Southern Neighbourhood" to discuss recent developments in the field of human rights and the rule of law in Algeria. The hearing will be held in association with the standing delegation for relations with the Maghreb countries (DMAG).

Full title: Strengthening Europe's open strategic autonomy: The need for a 'bold Europe'

This event will be held in the Library Reading Room of the European Parliament in Brussels. If you have an accreditation or an EU Institutions security badge you can enter freely the Spinelli building.

If you don't or if you prefer, you can watch the event live by clicking the below link.

[...] Why we still participate in this ancient ritual and why it’s essential to democratic discourse

If you have an EU Institutions security badge or an accreditation to the EP, you can attend the event in the library. If you don't or if you prefer you can attend the event live on Webex (see the link below)

On 21 March, the Committee on Development holds a public hearing on how to create sustainable and decent employment opportunities in Africa for its increasingly young population.

EU regions in a "development trap": Targeted solutions through cohesion policy instruments

On 22 March, the EMPL Committee will hold a public hearing on “Working conditions of firefighters”. The World Health Organisation recently re-classified firefighters as a profession that is vulnerable to carcinogenics. This hearing will inform the EMPL committee’s work in various areas, and in particular the ongoing revision of the Asbestos at Work Directive.

In the perspective of a possible convention for the revision of the EU Treaties, it is important to discuss the ways of strengthening the EU’s institutional, budgetary and decision-making arrangements in the common foreign and security policy by means of treaty changes.

Advanced Therapy Medicinal Products (ATMP) refers to new medical products that use gene therapy, cell therapy, and tissue engineering. They can be used to treat diseases or injuries, such as skin in burns victims, Alzheimer's, and cancer or muscular dystrophy, and have huge potential for the future of medicine.